A patient with Fechtner syndrome successfully treated with romiplostim

Thrombosis and Haemostasis

Volumn 107, Issue 3, 2012, Pages 590-591

  Gröpper, Stefanie ^a   Althaus, Karin ^b   Najm, Juliane ^b   Haase, Sabine ^a   Aul, Carlo ^a   Greinacher, Andreas ^b   Giagounidis, Aristoteles ^a  

^a ST JOHANNES HOSPITAL   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ELTROMBOPAG; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ROMIPLOSTIM;

AUTOSOMAL DOMINANT DISORDER; BLEEDING; BONE MARROW BIOPSY; DRUG DOSE INCREASE; DRUG MEGADOSE; FECHTNER SYNDROME; FOLLOW UP; GENE; GENE MUTATION; HEMODIALYSIS; HUMAN; LETTER; MEDICAL HISTORY; MUTATIONAL ANALYSIS; MYELOFIBROSIS; MYH9 GENE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; BLOOD PLATELETS; CATARACT; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MOLECULAR MOTOR PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; NEPHRITIS, HEREDITARY; PLATELET COUNT; PLATELET TRANSFUSION; RECEPTORS, FC; RECEPTORS, THROMBOPOIETIN; RECOMBINANT FUSION PROTEINS; RENAL DIALYSIS; RENAL INSUFFICIENCY; THROMBOCYTOPENIA; THROMBOPOIETIN; TREATMENT FAILURE;

EID: 84857736127     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-07-0474     Document Type: Letter

References (7)

1. Peterson LC, Rao KV, Crosson JT, et al. Fechtner syndrome--a variant of alport's syndrome with leukocyte inclusions and macrothrombocytopenia. Blood 1985; 65: 397-406.
2. Kunishima S, Matsushita T, Kojima T, et al. Identification of six novel myh9 mutations and genotypephenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet 2001; 46: 722-729.
3. Seri M, Cusano R, Gangarossa S, et al. Mutations in myh9 result in the may-hegglin anomaly, and fechtner and sebastian syndromes. The may-heggllin/ fechtner syndrome consortium. Nat Genet 2000; 26: 103-105.
4. Pecci A, Gresele P, Klersy C, et al. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from myh9 mutations. Blood 2010; 116: 5832-5837.
5. Savoia A, De Rocco D, Panza E, et al. Heavy chain myosin 9-related disease (myh9-rd): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. Thromb Haemost 2010; 103: 826-832.
6. Kuter DJ, Mufti GJ, Bain BJ, et al. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood 2009; 114: 3748-3756.
7. Kantarjian H, Fenaux P, Sekeres MA, et al. Safety and efficacy of romiplostim in patients with lowerrisk myelodysplastic syndrome and thrombocytopenia. J Clin Oncol 2010; 28: 437-444.